The EHA Research Roadmap: Malignant Lymphoid Diseases.

Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P, Stilgenbauer S, Fox C, Maria Ribera J, Zweegman S, Aurer I, Bödör C, Burkhardt B, Buske C, Dollores Caballero M, Campo E, Chapuy B, Davies A, de Leval L, Doorduijn J, Federico M, Gaulard P, Gay F, Ghia P, Grønbæk K, Goldschmidt H, Kersten MJ, Kiesewetter B, Landman-Parker J, Le Gouill S, Lenz G, Leppä S, Lopez-Guillermo A, Macintyre E, Mantega MVM, Moreau P, Moreno C, Nadel B, Okosun J, Owen R, Pospisilova S, Pott C, Robak T, Spina M, Stamatopoulos K, Stary J, Tarte K, Tedeschi A, Thieblemont C, Trappe RU, Trümper LH, Salles G

Open source

DOI
10.1097/hs9.0000000000000726
Published
2022 Jun
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/hs9.0000000000000726,
  title = {The EHA Research Roadmap: Malignant Lymphoid Diseases.},
  author = {Dreyling M and André M and Gökbuget N and Tilly H and Jerkeman M and Gribben J and Ferreri A and Morel P and Stilgenbauer S and Fox C and Maria Ribera J and Zweegman S and Aurer I and Bödör C and Burkhardt B and Buske C and Dollores Caballero M and Campo E and Chapuy B and Davies A and de Leval L and Doorduijn J and Federico M and Gaulard P and Gay F and Ghia P and Grønbæk K and Goldschmidt H and Kersten MJ and Kiesewetter B and Landman-Parker J and Le Gouill S and Lenz G and Leppä S and Lopez-Guillermo A and Macintyre E and Mantega MVM and Moreau P and Moreno C and Nadel B and Okosun J and Owen R and Pospisilova S and Pott C and Robak T and Spina M and Stamatopoulos K and Stary J and Tarte K and Tedeschi A and Thieblemont C and Trappe RU and Trümper LH and Salles G},
  year = {2022},
  journal = {HemaSphere},
  doi = {10.1097/hs9.0000000000000726},
  url = {https://doi.org/10.1097/hs9.0000000000000726}
}

RIS

TY  - JOUR
TI  - The EHA Research Roadmap: Malignant Lymphoid Diseases.
AU  - Dreyling M
AU  - André M
AU  - Gökbuget N
AU  - Tilly H
AU  - Jerkeman M
AU  - Gribben J
AU  - Ferreri A
AU  - Morel P
AU  - Stilgenbauer S
AU  - Fox C
AU  - Maria Ribera J
AU  - Zweegman S
AU  - Aurer I
AU  - Bödör C
AU  - Burkhardt B
AU  - Buske C
AU  - Dollores Caballero M
AU  - Campo E
AU  - Chapuy B
AU  - Davies A
AU  - de Leval L
AU  - Doorduijn J
AU  - Federico M
AU  - Gaulard P
AU  - Gay F
AU  - Ghia P
AU  - Grønbæk K
AU  - Goldschmidt H
AU  - Kersten MJ
AU  - Kiesewetter B
AU  - Landman-Parker J
AU  - Le Gouill S
AU  - Lenz G
AU  - Leppä S
AU  - Lopez-Guillermo A
AU  - Macintyre E
AU  - Mantega MVM
AU  - Moreau P
AU  - Moreno C
AU  - Nadel B
AU  - Okosun J
AU  - Owen R
AU  - Pospisilova S
AU  - Pott C
AU  - Robak T
AU  - Spina M
AU  - Stamatopoulos K
AU  - Stary J
AU  - Tarte K
AU  - Tedeschi A
AU  - Thieblemont C
AU  - Trappe RU
AU  - Trümper LH
AU  - Salles G
PY  - 2022
JO  - HemaSphere
DO  - 10.1097/hs9.0000000000000726
UR  - https://doi.org/10.1097/hs9.0000000000000726
ER  -

APA

M, D., M, A., N, G., H, T., M, J., J, G., A, F., P, M., S, S., C, F., J, M. R., S, Z., I, A., C, B., B, B., C, B., M, D. C., E, C., B, C., A, D., L, D. L., J, D., M, F., P, G., F, G., P, G., K, G., H, G., MJ, K., B, K., J, L., S, L. G., G, L., S, L., A, L., E, M., MVM, M., P, M., C, M., B, N., J, O., R, O., S, P., C, P., T, R., M, S., K, S., J, S., K, T., A, T., C, T., RU, T., LH, T., & G, S. (2022). The EHA Research Roadmap: Malignant Lymphoid Diseases.. HemaSphere. https://doi.org/10.1097/hs9.0000000000000726

Source records